Patents by Inventor Andrew Boyd

Andrew Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140197707
    Abstract: A primary disc and the secondary discs are each fitted with magnetic means, typically in the form of permanent magnets of the same polarity, located along a radial line from the centre point of the discs, and arranged generally transverse to the axis of rotation of the respective disc. These magnets are also located at or adjacent to the periphery of the disc(s). The magnets are embedded into each of the primary and secondary discs such that the faces of the magnets are flush with the exterior faces of the primary and secondary discs. In some embodiments, the magnets on the primary and secondary discs are arranged so as to be parallel, with their respective elongate, straight side edges aligned. Such an arrangement can result in less slippage between the discs which hold the magnets, and can assist in handling some misalignment which may occur between these discs during use, thus allowing smoother operation.
    Type: Application
    Filed: July 15, 2013
    Publication date: July 17, 2014
    Inventor: Andrew Boyd FRENCH
  • Patent number: 8772275
    Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: July 8, 2014
    Assignee: Curis, Inc.
    Inventors: Lee L. Rubin, Oivin Guicherit, Stephen Price, Edward Andrew Boyd
  • Patent number: 8667184
    Abstract: An improved distributed operating system over a network of computer systems is described. Existing distributed operating systems have transmission performance limitations dictated by their inability to (1) reliably handle transient communication failures and rapid node reboots, (2) provide a transmission protocol that adapts to link reliability, and (3) allow transmissions to occur over an arbitrary combination of communication links. The systems and methods described herein solve these problems by providing a reliable node-to-node session protocol that offers high performance message delivery and multi-interface management and support. This is done by transmitting all data between two nodes of the operating system over a single connection that may dynamically exploit multiple interfaces between the nodes.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: March 4, 2014
    Assignee: QNX Software Systems Limited
    Inventor: Andrew Boyd
  • Publication number: 20130285497
    Abstract: A primary disc and the secondary discs are each fitted with magnetic means, typically in the form of permanent magnets of the same polarity, located along a radial line from the centre point of the discs, and arranged generally transverse to the axis of rotation of the respective disc. These magnets are also located at or adjacent to the periphery of the disc(s). The magnets are embedded into each of the primary and secondary discs such that the faces of the magnets are flush with the exterior faces of the primary and secondary discs. In some embodiments, the magnets on the primary and secondary discs are arranged so as to be parallel, with their respective elongate, straight side edges aligned. Such an arrangement can result in less slippage between the discs which hold the magnets, and can assist in handling some misalignment which may occur between these discs during use, thus allowing smoother operation.
    Type: Application
    Filed: April 19, 2012
    Publication date: October 31, 2013
    Inventor: Andrew Boyd FRENCH
  • Publication number: 20130119804
    Abstract: A magnetic coupling comprising: an outer support having an interior cavity defined by an cavity periphery and being rotatable around an axis of rotation, the outer support having a plurality of outer magnets arranged at or adjacent the cavity periphery; an inner support at least a portion of which is located within the cavity, the inner support being rotatable about an axis and having a plurality of inner magnets arranged around and at or adjacent to a periphery wherein the inner magnets and the outer magnets are arranged such that at a given time, at least a portion of at least some of the inner magnets are located between at least a portion of at least some of the outer magnets.
    Type: Application
    Filed: January 7, 2013
    Publication date: May 16, 2013
    Inventor: Andrew Boyd French
  • Publication number: 20130048296
    Abstract: An apparatus and method for connecting an umbilical to a marine riser is provided. The method and apparatus can be employed in instances when a riser is already in place in the water, extending from a drilling vessel to subsea equipment on the ocean floor.
    Type: Application
    Filed: August 25, 2011
    Publication date: February 28, 2013
    Applicant: Chevron Corporation
    Inventors: Thomas B. Heyward, John Rodney Hensely, Evan P. Graybill, Andrew Boyd, Kalyan Vajapeyajula, Andreas Stamatiou
  • Patent number: 8386586
    Abstract: An improved distributed operating system over a network of computer systems is described. Existing distributed operating systems have transmission performance limitations dictated by their inability to (1) reliably handle transient communication failures and rapid node reboots, (2) provide a transmission protocol that adapts to link reliability, and (3) allow transmissions to occur over an arbitrary combinations of communication links. The systems and methods described herein solve these problems by providing a reliable node-to-node session protocol that offers high performance message delivery and multi-interface management and support. This is done by transmitting all data between two nodes of the operating system over a single connection that may dynamically exploit multiple interfaces between the nodes.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: February 26, 2013
    Assignee: QNX Software Systems Limited
    Inventor: Andrew Boyd
  • Patent number: 8354397
    Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: January 15, 2013
    Assignee: Curis, Inc.
    Inventors: Lee L. Rubin, Oivin Guicherit, Stephen Price, Edward Andrew Boyd
  • Patent number: 8314257
    Abstract: The present invention provides indole derivatives that antagonize prostaglandin D2, and that can be used to treat inflammatory diseases mediated by prostaglandin D2.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: November 20, 2012
    Assignee: Oxagen Limited
    Inventors: David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker, Chris Palmer, Eric R. Pettipher
  • Publication number: 20120283258
    Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.
    Type: Application
    Filed: March 16, 2012
    Publication date: November 8, 2012
    Applicants: CURIS, INC., GENENTECH, INC.
    Inventors: Oivin M. GUICHERIT, Edward Andrew BOYD, Judith Boyd, Shirley Ann BRUNTON, Stephen PRICE, John Harry Alexander STIBBARD, Colin H. MACKINNON
  • Publication number: 20120179777
    Abstract: An improved distributed operating system over a network of computer systems is described. Existing distributed operating systems have transmission performance limitations dictated by their inability to (1) reliably handle transient communication failures and rapid node reboots, (2) provide a transmission protocol that adapts to link reliability, and (3) allow transmissions to occur over an arbitrary combinations of communication links. The systems and methods described herein solve these problems by providing a reliable node-to-node session protocol that offers high performance message delivery and multi-interface management and support. This is done by transmitting all data between two nodes of the operating system over a single connection that may dynamically exploit multiple interfaces between the nodes.
    Type: Application
    Filed: November 9, 2011
    Publication date: July 12, 2012
    Inventor: Andrew Boyd
  • Patent number: 8198298
    Abstract: Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.
    Type: Grant
    Filed: February 14, 2011
    Date of Patent: June 12, 2012
    Assignee: Pfizer Italia S.r.l.
    Inventors: Barbara Salom, Matteo D'Anello, Maria Gabriella Brasca, Patrizia Giordano, Katia Martina, Dania Tesei, Frederick Arthur Brookfield, William John Trigg, Edward Andrew Boyd, Jonathan Anthony Larard
  • Patent number: 8198314
    Abstract: The present invention provides indole derivatives that antagonize prostaglandin D2, and that can be used to treat inflammatory diseases mediated by prostaglandin D2.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: June 12, 2012
    Assignee: Oxagen Limited
    Inventors: David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker, Chris Palmer, Eric R. Pettipher
  • Patent number: 8168653
    Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: May 1, 2012
    Assignees: Curis, Inc., Genentech, Inc.
    Inventors: Oivin M. Guicherit, Edward Andrew Boyd, Shirley Ann Brunton, Stephen Price, John Harry Alexander Stibbard, Colin H. Mackinnon
  • Patent number: 8163936
    Abstract: The present invention provides indole derivatives that antagonize prostaglandin D2, and that can be used to treat inflammatory diseases mediated by prostaglandin D2.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: April 24, 2012
    Assignee: Oxagen Limited
    Inventors: David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker, Chris Palmer, Eric R. Pettipher
  • Patent number: 8163931
    Abstract: The present invention provides indole derivatives that antagonize prostaglandin D2, and that can be used to treat inflammatory diseases mediated by prostaglandin D2.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: April 24, 2012
    Assignee: Oxagen Limited
    Inventors: David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker, Chris Palmer, Eric R. Pettipher
  • Patent number: 8129425
    Abstract: The present invention makes available methods and reagents for modulating proliferation or differentiation in a cell or tissue comprising contacting the cell with a hedgehog agonist, such as the compounds depicted in FIGS. 32 and 33. In certain embodiments, the methods and reagents may be employed to correct or inhibit an aberrant or unwanted growth state, e.g., by antagonizing a normal ptc pathway or agonizing smoothened or hedgehog activity.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: March 6, 2012
    Assignee: Curis, Inc.
    Inventors: Anthony David Baxter, Edward Andrew Boyd, Maria Frank-Kamenetsky, Oivin Guicherit, Jeffery Porter, Stephen Price, Lee Rubin, John Harry Alexander Stibbard
  • Publication number: 20120053777
    Abstract: Apparatus 10 for detecting inadequate maintenance of a system 12 of an aircraft or other vehicle is provided. The apparatus comprises: computer readable medium or media 14 configured to store data 18 relating to operation or non-operation of the system 12 over a period of time; and a data processing unit 16 configured to evaluate the data to identify at least one event indicative of the inadequate maintenance of the system.
    Type: Application
    Filed: August 31, 2010
    Publication date: March 1, 2012
    Applicant: PRATT & WHITNEY CANADA CORP.
    Inventors: David Benjamin Meisels, Peter Andrew Boyd
  • Patent number: 8106069
    Abstract: Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: January 31, 2012
    Assignee: Pfizer Italia S.r.l.
    Inventors: Barbara Salom, Matteo D'Anello, Maria Gabriella Brasca, Patrizia Giordano, Katia Martina, Francesco Angelucci, Frederick Arthur Brookfield, William John Trigg, Edward Andrew Boyd, Jonathan Anthony Larard
  • Patent number: 8080567
    Abstract: A compound of formula (III): or a salt, solvate and chemically protected form thereof, wherein: R5 is an optionally substituted C5-20 aryl or C4-20alkyl group; L? is a single bond, —O— or —C(?O)—; A is selected from the group consisting of: formula (i) (ii) (iii) wherein X and Y are selected from the group consisting of: O and CR3; S and CR3; NH and CR3; NH and N; O and N; S and N; N and S; and N and O, and where the dotted lines indicate a double bond in the appropriate location, and where Q is either N or CH; D is selected from: formula (i) (ii) (iii) (iv) (v) (vii) (viii) (ix) B is selected from the group consisting of: formula (A) (B) where RP6 is selected from fluoro and chloro; and R2 is either: (i) —CO2H; (ii) —CONH2; (iii) —CH2—OH; or (iv) tetrazol-5-yl.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: December 20, 2011
    Assignee: Asterand UK Limited
    Inventors: Alexander William Oxford, Richard Jon Davis, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Shirley Ann Brunton, Neil Victor Harris, Garry Fenton, George Hynd, Keith Alfred James Stuttle, Jonathan Mark Sutton, Mark Richard Ashton, Edward Andrew Boyd